A new AAN position statement outlines guidelines for switching from branded biologics to biosimilars, while preserving clinical autonomy for physicians.
Nokia today provides recast comparative segment financial information on a quarterly and annual basis for 2025, and on an annual basis for 2024, reflecting the previously announced changes in its ...
C3383CSTMicroelectronics Reports Q4 and FY 2025 Financial Results Q425 net revenues $3.33 billion; gross margin 35.2%; operating income of ...
EET Nokia provides recast comparative segment results for 2025 and 2024 reflecting new operating and financial reporting structure Nokia ...
Juniata Valley Financial Corp. (OTCQX:JUVF) ("Juniata"), announced net income for the three months ended December 31, 2025 of $2.0 million, an increase ...
In early 2024, the UK Financial Conduct Authority (FCA) announced that it intended to make it easier for itself to publish ...
Q4 2025 Earnings Call January 29, 2026 8:00 AM ESTCompany ParticipantsMatthew PallottaRobert Mionis - President, CEO ...
Rouse Law, P.C. is a Des Moines-based law firm dedicated to helping Iowans navigate the complexities of personal injury and ...
VANCOUVER, BC / ACCESS Newswire / January 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF ...
Q4/25Q4/24yoy12m/2512m/24yoySupermarkets157.0164.1-4.3%611.9610.40.3%Department ...
Strong operations and guidance raised - business development supports growth ...
Minerals Technologies Inc. (NYSE: MTX) (“MTI”), a leading, technology-driven specialty minerals company, today reported earnings per share for the fourth quarter ended December 31, 2025, of $1.19, or ...